期刊文献+

5-对甲苯磺酰氨基酞酰亚胺衍生物的设计合成及α-糖苷酶抑制活性

Design,synthesis and α-glucosidase inhibitory activity of 5-(p-toluenesulfonylamino) phthalimide derivatives
原文传递
导出
摘要 目的寻找具有新型结构的α-糖苷酶抑制剂类降血糖药物。方法 N-取代-5-对甲苯磺酰氨基酞酰亚胺类目标化合物(Ⅰ1~Ⅰ8)以邻苯二甲酰亚胺为起始物,经硝化后,通过烃化反应在亚胺氮上引入含芳基的不同取代结构,再经还原及磺酰化反应合成;N-取代结构的苯环上含有酚羟基的目标化合物(Ⅱ1~Ⅱ3)采用乙酰化保护后再进行还原及磺酰化、去保护基等步骤制得;目标化合物Ⅱ4和Ⅱ5的合成是以5-硝基酞酰亚胺为原料,先与甲醛反应,在亚胺氮上引入羟甲基,再与酚性结构进行偶联反应引入相应取代基,最后经还原及磺酰化制得。采用4-硝基苯-α-D-吡喃葡萄糖苷反应体系对目标化合物的α-糖苷酶抑制活性进行评价;采用计算机辅助药物设计软件进行分子Docking分析。结果合成了13个未见报道的新化合物,其结构经MS及1H-NMR谱确证。所有目标化合物对酵母α-糖苷酶均表现出明显的抑制活性,其IC50值小于阳性药物阿卡波糖(Acar);Docking分析显示,5-对甲苯磺酰氨基酞酰亚胺与酶活性催化位点的氨基酸残基能形成多个氢键,N-取代结构以疏水作用或氢键与酶分子产生相互作用而影响酶活性。结论 5-对甲苯磺酰氨基酞酰亚胺结构是产生α-糖苷酶抑制活性的有利结构,亚胺氮原子上取代结构对抑酶活性有重要影响,此结果得到分子对接分析的支持。 Multiple work has convincingly demonstrated that glycemic fluctuation is more deleterious than chronic sustained hyperglycemia as a key factor in contributing to diabetes and related complications. The α- glucosidase inhibitors reduce glucose fluctuations by inhibiting postprandial hyperglycemia and appear po- werful therapeutic in controlling postprandial hyperglycemia in Asian people because of their specific food habits. Discovery of o^-glucosidase inhibitors has" been actively pursued with the aim to develop therapeutics for the treatment of diabetes and related complications. In this study, a series of N-aromatic substituted-5- (p- toluenesulfonylamino) phthalimide derivatives were designed based on the pharmacophore model of ot-glu- cosidase inhibitors. The target compounds were synthesized with phthalimide as the starting material. Treat- ment of phthalimide with nitric acid gave 5-nitrophthalimide, which was reacted with different aromatic halo- genated hydrocarbons to afford N-substituted-5-nitrophthalimide and followed by reduction of formamide o- ver Pd/C catalyst and sulfonylation with p-toluenesulfonic acid. The substituted moiety in compounds N- ( 3,4-dihydroxyphenyl ) methyl -5 -nitrophthalimide and N- E ( 3 -hydroxy-4-hydroxyformylphenyl ) methyl ~ - 5-nitrophthalimide were produced by reaction of 5-nitrophthalimide and formaldehyde to afford N-hydroxym~ ethyl-5-nitrophthalimide, which was coupled with catechol and salylic acid respectively. Thirteen target com- pounds were obtained and their structures were confirmed by I H-NMR and MS data. The ot-glucosidase in- hibitory activity of the target compounds was evaluated on ye^tst oz-glucosidase. All of them show obvious ot- glucosidase inhibitory activity with much lower ICs0 value than that of acarbose. Molecular docking analysis revealed that 5-(p-toluenesulfonamino) phthalimide scaffold is able to bind with amino acids of the active site through forming multiple H-bond and hydrophobic interactions. The N-substituted rnoiety can also inter- act with protein by forming H-bond or hydrophobic force, which may impact the intension of the inhibitory activity of compounds. The toluenesulfonylamino phthalimide may be further optimized and other class of ot- glucosidase inhibitors may be designed according to the results of this study.
出处 《中国药物化学杂志》 CAS CSCD 2012年第5期341-348,共8页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(21172177)
关键词 酞酰亚胺类化合物 Α-糖苷酶抑制剂 化学合成 分子对接 phthalimide derivative α-glucosidase inhibitor chemical synthesis molecular docking
  • 相关文献

参考文献15

  • 1韦昭.糖尿病并发症的防治进展[J].中华实用心脑肺血管病杂志,2008,16(8).61-65.
  • 2MATTEO A. Cardiovascular prevention in type 2 di- abetes mellitus patients:the role of oral glucose-low- ering agents J ]. J Diabetes Complications, 2009,23 (2) :427 -433.
  • 3ZACCARDI F, PITOCCO D, GHIRLANDA G. Gly- cemic risk factors of diabetic vascular complications: the role of glycemic variability [ J ]. Diabetes MetabRes ,2009,25 ( 2 ) : 199 - 207.
  • 4CERIELLO A, ESPOSITO K, PICONI L, et al. Os- cillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients [ J ]. Diabetes, 2008,57 (5) : 1349 - 1354.
  • 5NALYSNYK L, HERNANDEZ-MEDINA M, KRISH- NARAJAH G. Glycaemic variability and complica- tions in patients with diabetes mellitus:evidence from a systematic review of the literature E J ]. Diabetes Obes Metab ,2010,12 (4) :288 - 298.
  • 6顾觉奋,陈紫娟.α-葡萄糖苷酶抑制剂的研究及应用[J].药学进展,2009,33(2):62-67. 被引量:73
  • 7HWANGSEO P, KYO Y H, KYUNG H O, et al. Discovery of novel ot-glucosidase irthibitors based on the virtual screening with the homology-modeled protein structure E J ]- Bioorg Med Chem, 2008, 16 (1) :284 -292.
  • 8KAVITHA B, NAGAKUMAR B, KI H P, et al. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of ot-glucosidase inhibitors J 1. J Mol Graph Model,2008,26(8) :1202 -1212.
  • 9MICHIRU Y, YOUICHI T, FUMIKO M. Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid a-glu- cosidase( alglucosidase alfa) :insight into the com- plex formation mechanism E J ]. Clin Chim Acta, 2008,391 ( 1 ) :68 -73.
  • 10俞马金,张凡.4-硝基邻苯二甲腈的合成研究[J].化工科技,2001,9(2):16-18. 被引量:7

二级参考文献67

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部